Times China (1233) H1 2024 earnings summary
Event summary combining transcript, slides, and related documents.
H1 2024 earnings summary
12 Dec, 2025Executive summary
Revenue for the six months ended 30 June 2024 was RMB6,091.0 million, down 38.7% year-over-year, mainly due to reduced property sales and area delivered.
Loss for the period increased to RMB2,831.4 million, up 100.9% from the prior year, primarily due to higher asset impairment.
Core net loss was RMB2,827.9 million, up RMB1,417.6 million year-over-year.
Contracted sales fell 54.5% to RMB4.291 billion, with average sales price per sq.m. down 22.9% year-over-year.
No interim dividend was declared and no income was generated from the urban redevelopment business during the period.
Financial highlights
Gross profit was RMB537.3 million, down 29.3% year-over-year; gross profit margin was 8.8%, stable versus 7.7% last year.
Cost of sales fell 39.5% to RMB5,553.7 million, reflecting lower area delivered.
Other expenses rose 158% to RMB2,322.3 million, mainly due to increased asset impairment.
Finance costs were RMB581.2 million, similar to the prior year.
Cash and bank balances at 30 June 2024 were RMB3,370.1 million, with restricted deposits of RMB1,828.9 million, down 15.2% from year-end 2023.
Outlook and guidance
The company expects continued pressure on new property prices and slow inventory digestion, with second-hand housing transactions likely outperforming new homes.
Management anticipates ongoing policy support but expects a sluggish market and slow recovery.
Plans include aggressive sales, cost control, debt management, and asset disposals to stabilize cash flow and support long-term sustainability.
Latest events from Times China
- Revenue plunged and losses narrowed after debt restructuring, but going concern risks persist.1233
H2 202530 Mar 2026 - Revenue plunged 62.8% and net loss deepened, with major liquidity and restructuring risks persisting.1233
H1 202512 Dec 2025 - Severe losses, liquidity crisis, and major debt restructuring define the year's results.1233
H2 202412 Dec 2025